Overview

Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites

Status:
Completed
Trial end date:
2012-06-27
Target enrollment:
Participant gender:
Summary
Bioequivalence of propafenone hydrochloride capsules manufactured at two different sites
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Propafenone